Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Pediatr Urol. 2016 Apr 16;12(4):232.e1–232.e6. doi: 10.1016/j.jpurol.2016.03.014

Open versus minimally invasive ureteroneocystostomy: a population-level analysis

Hsin-Hsiao S Wang a, Rohit Tejwani a, Glenn M Cannon Jr b, Patricio C Gargollo c, John S Wiener a, Jonathan C Routh a,*
PMCID: PMC5012942  NIHMSID: NIHMS783166  PMID: 27140001

Summary

Introduction

Open ureteroneocystostomy (UNC) is the gold standard for surgical correction of vesicoureteral reflux (VUR). Beyond single-center reports, there are few published data on outcomes of minimally invasive (MIS) UNC. Our objective was to compare postoperative outcomes of open and MIS UNC using national, population-level data.

Method

We reviewed the 1998–2012 Nationwide Inpatient Sample to identify pediatric (≤18 years) VUR patients who underwent either open or MIS UNC. Demographics, National Surgical Quality Improvement Program (NSQIP) complications, length of stay (LOS), and cost data were extracted. Statistical analysis was performed using weighted, hierarchical multivariate logistic regression (complications) and negative binomial regression (LOS, cost).

Results

We identified 780 MIS and 75,976 open UNC admissions. Compared with patients undergoing open UNC, patients who underwent MIS UNC were likely to be older (6.2 versus 4.8 years, p<0.001), publically insured (43 versus 26%, p<0.001), and treated in recent years (90 versus 46% after 2005, p<0.001). MIS admissions were associated with a significantly shorter length of stay (1.0 versus 1.8 days, p<0.001) and higher cost ($9,230 versus $6,304, p=0.002). After adjusting for patient-level confounders (age, gender, insurance, treatment year, and comorbidity), and hospital-level factors (region, bedsize, and teaching status), MIS UNC was associated with a significantly higher rate of postoperative urinary complications such as UTIs, urinary retention, and renal injury (OR 3.1, p=0.02), shorter LOS (RR 0.8, p=0.02), and higher cost (RR 1.4, p=0.008).

Discussion

Strengths of this study are its large cohort size, long time horizon, national estimation, and cost data. Most prior studies are case-series limited to the size of the institutional cohort. Our analysis of 76,756 operative encounters revealed that open UNC continues to be performed at far greater frequency than MIS UNC, outpacing the latter modality by nearly 100:1. Children treated with MIS UNC had three times greater odds of developing postoperative urinary complications, and MIS UNC patients incurred average costs per admission that were nearly 1.5 times higher than those of children who underwent open UNC. These children were also likely to be older, publically insured, and treated in more recent years. On the other hand, patients treated with MIS UNC required substantially shorter postoperative hospitalization, with an average LOS roughly half that of open UNC cases. Limitations include the retrospective nature of the administrative database, lack of detailed patient-level data, and no available long-term postoperative outcomes. Compared with open surgery, MIS UNC was associated with shorter LOS but higher costs and possibly higher urinary complication rates.

Keywords: Vesicoureteral reflux, Complication, Surgery, Ureteroneocystostomy, Minimally invasive

INTRODUCTION

Vesicoureteral reflux (VUR) is a commonly encountered problem in pediatric urologic practice, affecting approximately 1% of all children and up to 70% of those presenting with a febrile UTI [1]. Given this common incidence, the economic impact from VUR has been found to be significant, with care-related charges exceeding $100 million annually in the USA [2]. Optimal management strategies for this condition are controversial and continue to be debated as our understanding of its pathophysiology, clinical course, and long-term sequelae evolve [3,4]. Although the vast majority of cases of VUR resolve spontaneously and do not require surgical management, surgical interventions may be warranted in patients with persistent VUR and/or recurrent febrile UTI to reduce risk of renal scarring and loss of kidney function [3,5].

Open ureteroneocystostomy (UNC) has served as the cornerstone of surgical management of VUR for over 50 years and continues to play a prominent role in modern management algorithms [6,7]. Endoscopic correction of VUR with injection of bulking agents has been available in the USA for over 10 years, but its success rate has never equaled that of UNC, particularly in higher grades of VUR [8]. Significant advances in laparoscopic and robotic technology have coupled with a paradigm shift among providers and families favoring preferential use of less-invasive surgical approaches in children and resulted in a rise in the use of minimally invasive surgery (MIS) in pediatric urology, including MIS-UNC [9]. Yet, despite substantial differences in invasiveness, cost, and intra/postoperative characteristics, there are few multi-center studies directly comparing operative outcomes between open and MIS UNC approaches [9]. Given current efforts to improve care quality and optimize cost management, broader-encompassing comparisons are particularly salient.

We sought to characterize postoperative outcomes, including length of stay (LOS), cost, and National Surgical Quality Improvement Program (NSQIP) postoperative complication rates, for pediatric (aged ≤18 years) patients who underwent surgical intervention for VUR with either open or MIS UNC between 1998 and 2012 using the Nationwide Inpatient Sample (NIS), a nationally representative inpatient administrative database. We hypothesized that complication rates and cost would be higher for MIS surgeries, whereas LOS would be longer for open surgeries.

Materials and methods

Data source

NIS is an all-payer database managed by the Healthcare Cost and Utilization Project (HCUP) and sponsored by the Agency for Healthcare Research and Quality (AHRQ). NIS is derived from a 20% stratified probability sample of US hospitals, including both children’s and adult hospitals, based on five hospital characteristics including ownership status, number of beds, teaching status, urban/rural location, and geographic region. NIS includes post-stratification discharge weights that may be used to calculate national estimates [10].

Selection of patients and covariates

We identified all inpatient hospital encounters occurring between 1998 and 2012 for pediatric patients (aged ≤18 years) with an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis code for VUR (593.7) who underwent UNC (56.74). MIS UNC was differentiated from open UNC using additional procedure codes 17.4, 54.21, 54.51, indicative of UNC involving robotic surgery (17.4) or laparoscopy (54.21, 54.51).

Predictor variables were a priori selected based on biologic plausibility and/or demonstrated associations in the literature. Covariates included basic patient demographics: age, gender, race, insurance payer (public vs. private), median household income quartiles by zip code, Charlson comorbidity index, treatment year, and treatment modality (open versus MIS). We also extracted hospital-level factors: hospital characteristics such as hospital teaching status (metropolitan non-teaching, metropolitan teaching, and non-metropolitan) and geographic region (Northeast, South, Midwest, and West), and center size.

Outcome selection

The primary outcome was in-hospital postoperative complications; these were identified by the ICD-9-CM code (Appendix 1) as defined by NSQIP [11,12]. We included UTI, postoperative urinary complications including urinary retention, acute renal insufficiency, urinary tract infections (ICD-9-CM diagnosis code 997.5), pneumonia, and bleeding as the main outcomes. We also examined length of stay (LOS), and total hospital costs per admission. Rare complications (n≤15) were removed from the analysis as per AHRQ regulations prohibiting publication of rare events. Among the NSQIP-identified complications, there were too few events for postoperative surgical site infection (superficial and deep), peritoneal abscess, acute renal failure, respiratory complications, ARDS, pulmonary embolism, postoperative respiratory insufficiency, prolonged mechanical ventilation (>96 hours), sepsis, cerebrovascular accident, postoperative cardiac complications, acute myocardial infarction, cardiac arrest or other cardiac complications, deep vein thrombus, or in-hospital death to perform a thorough analysis; these complications were, therefore, excluded.

Appendix 1.

Complications ICD-9 codes
SSI (superficial) 998.32
SSI (deep) 998.31
Peritoneal abscess 567.22
UTI 599
Urinary complications 997.5
ARF 584.x, 586.x
Resp complications 997.3
Pneumonia 481–487, 507
Post-OP resp. insufficiency 518.5
ARDS 518.82
Systemic Sepsis 790.7, 038.x
PE 415.1, 415.11, 415.19
Vent >96h 96.72
CVA 997.02
Cardiac complications 997.1
MI 410.x
Cardiac arrest 427.5
Bleeding 285.1, 998.11
DVT 453.4, 453.40, 453.9

Statistical analysis

Bivariate analyses were performed to compare patient demographics and hospital-level characteristics of patients who received open and MIS UNC. We used the Rao-Scott chi square test, t test, or Wilcoxon rank-sum test as appropriate based on data characteristics and distribution. All analyses were weighted using NIS-specific estimated weights and covariance matrices accounting for the complex survey design. NIS cost-to-charge files were used to convert hospital charges to cost [2]. Multivariate logistic regression (NSQIP in-hospital postoperative complications, in-hospital deaths) and negative binomial regression (LOS, cost) were fitted to examine factors, specifically surgical modality (open versus MIS), that predicted the outcomes. Generalized estimating equations were used to account for complex survey design of NIS in addition to hospital clustering effects.

An alpha of 0.05 and 95% CI were used as criteria for statistical significance. All analyses were performed using SAS 9.4 (SAS Institute, Cary, NC, USA).

Ethical approval

This protocol was reviewed by the Duke Institutional Review Board and deemed exempt from review. Administrative approval was given by HCUP.

Results

Demographics

UNC (Table 1). Mean patient age was 4.8±0.1 years. Males constituted 26% of the overall cohort. Most of the patients (87%) received UNC in an urban teaching hospital.

Table 1.

Patient and hospital characteristics by surgery type

Characteristics Total (n=76,756) MIS (%) (n=780) Open (%) (n=75,976) p value
Age in years (mean, SD) 4.8 (0.1) 6.2 (0.4) 4.8 (0.1) <0.001
Gender 0.62
 Male 19,981 184 (24) 19,797 (26)
 Female 56,064 579 (74) 55,485 (73)
Insurance 0.001
 Public 20,393 334 (43) 20,059 (26)
 Private 51,571 392 (50) 51,179 (67)
 Others 4,791 54 (7) 4,737 (6)
Treatment year <0.001
 1998–2004 41,246 79 (10) 41,167 (54)
 2005–2012 35,509 701 (90) 34,808 (46)
Income 0.11
 Q1 8,755 159 (20) 8,596 (11)
 Q2 11,483 140 (18) 11,343 (15)
 Q3 12,514 259 (33) 12,255 (16)
 Q4 13,348 172 (22) 13,176 (17)
Hospital region 0.20
 Northeast 16,344 175 (22) 16,169 (21)
 Midwest 17,825 180 (23) 17,645 (23)
 South 25,089 124 (16) 24,965 (33)
 West 17,496 300 (39) 17,196 (23)
Teaching hospital 0.29a
 Rural 1,772 0 1,772 (2)
 Urban-nonteaching 7,858 49 (6) 7,809 (10)
 Urban-teaching 67,036 726 (93) 66,310 (87)
Hospital bed size 0.03
 Small 13,196 39 (5) 13,157 (17)
 Medium 20,067 361 (46) 19,706 (26)
 Large 43,402 374 (48) 43,028 (57)
Length of stay (median, IQR) 1.8 (1.8) 1.0 (0.7) 1.8 (1.8) <0.001
Total cost (median, IQR) 6,282 (4,129) 9,230 (7,577) 6,304 (4,138) 0.002
a

Rao-Scott chi square for rural-teaching versus non-teaching.

Compared with patients undergoing open UNC, patients who underwent MIS UNC were likely to be older (6.2 versus 4.8 years, p<0.001), publically insured (43% versus 26%, p<0.001), treated in recent years (90% versus 46% after 2005, p<0.001), and at larger hospitals (94% versus 83% in medium-sized hospitals, p=0.02).

Postoperative complications

On bivariate analysis (Table 2), patients who received MIS UNC were more likely to suffer from ICD-9-identified “postoperative urinary complications” (OR 2.63, p=0.04) compared with patients who received open UNC. No significant difference was observed in rates of postoperative urinary tract infection or overall complications.

Table 2.

NSQIP postoperative complications by surgery type

NSQIP complications Total N=76,756 (%) MIS
N=780(%)
Open
N=75,976(%)
UTI 5,281 (6.88) 53 (6.79) 5,228 (6.88)
Urinary complications 827 (1.08) 21 (2.69) 806 (1.06)
All complications 6,955 (9.06) 80 (10.26) 6,875 (9.05)

After adjusting for age, gender, insurance, year, comorbidity, and hospital-level factors (teaching status, region, and hospital size) (Summary Table), VUR patients who underwent MIS UNC remained more likely to suffer from postoperative urinary complications (OR 3.13, p=0.02) compared with patients who underwent open UNC.

Table.

Bivariate/multivariate analysis of postoperative complications for MIS UNC

NSQIP complicationsa Unadjusted OR (95% CI) Adjusted ORb (95% CI) p valueb
UTI 1.00 (0.37–2.72) 0.99 (0.40–2.44) 0.98
Urinary complications 2.63 (1.00–6.91) 3.13 (1.17–8.40) 0.02
All complications 1.15 (0.48–2.78) 1.27 (0.57–2.85) 0.56
a

Using open UNC as reference.

b

After adjusting for age, gender, insurance, year, comorbidity, teaching status, hospital region, and hospital size.

Economic impact

On bivariate analysis, compared with VUR admissions received, open UNC, MIS UNC admissions were associated with a shorter median length of stay (1.0 versus 1.8 days, p<0.001; Table 1). This trend was notable even after adjusting for age, gender, insurance, treatment year, comorbidity, hospital teaching status, hospital region, and hospital size (RR 0.80, p=0.02; Table 3).

Table 3.

Bivariate/multivariate analysis of LOS and cost for MIS UNC

Economic outcomesa Unadjusted RR (95% CI) Adjusted RRb (95% CI) valueb p
LOS 0.74 (0.62–0.89) 0.80 (0.66–0.97) 0.02
Cost 1.47 (1.15–1.87) 1.40 (1.09–1.80) 0.01
a

Using open UNC as reference.

b

After adjusting for age, gender, insurance, year, comorbidity, teaching status, hospital region, and hospital bedsize.

Similarly, MIS UNC were found to have significantly higher median overall inpatient costs per admission ($9,230 versus $6,304, p=0.002). After adjusting for age, gender, insurance, treatment year, comorbidity, hospital teaching status, hospital region, and hospital size, MIS UNC admissions remained significantly associated with increased hospital cost (RR 1.40, p=0.01). There was no significant trend in MIS cost over time (p=0.84).

DISCUSSION

To our knowledge, this study is the largest investigating surgical outcomes on open versus MIS UNC. Our analysis of 76,756 operative encounters revealed that open UNC continues to be performed at far greater frequency than MIS UNC, outpacing the latter modality by nearly 100:1. This is not surprising as open UNC has long been the gold standard for surgical management of reflux in children. One of the earliest descriptions of open UNC in the treatment of VUR was published by Politano and Ledbetter in 1958, with further descriptions by Glenn, Anderson, Cohen, and others throughout the 1960s [1315]. Open UNC has been proven highly effective, with studies demonstrating successful resolution of reflux following initial treatment in more than 95% of patients and a further 57% risk reduction in the development of future febrile UTIs [15].

By comparison, the history of MIS UNC is considerably more recent, with laparoscopic UNC first successfully employed in children by Ehrlich in 1994, and robotic-assisted UNC by Peters et al. a decade later [7,16]. Initial success in reflux resolution following treatment with MIS UNC was far more variable, likely as a result of lack of provider experience with such approaches and the resultant learning curve [1621]. More recent series have found treatment efficacy with MIS UNC to be higher, although typically still not as high as open UNC [9,19,20,22]. MIS UNC has been associated with decreased postoperative pain and shorter LOS, as well as improved cosmesis and corresponding patient/parent satisfaction in some studies [21,23,24], although outpatient open UNC has been reported from several centers [25,26]. However, these benefits come at some expense, both clinically and financially. Several small cohort studies have mirrored our findings of increased incidences of postoperative urinary complications, often including urinary retention, urine leakage, and voiding dysfunction [21,24,27,28]. The reasons for this phenomenon are currently unknown and warrant additional future study, but may speculatively stem from nerve injury through the extravesical approach, lack of sufficient tactile feedback, and difficulty with fine instrument movements.

Despite shorter average LOS, patients in our cohort who underwent MIS UNC incurred per-admission costs nearly 1.5 times those of their open UNC counterparts. This may be partially attributable to higher cost incurred in the management of postoperative complications (i.e. urinary complications, as mentioned above). Additionally, high purchase and maintenance costs associated with advanced laparoscopic instruments, and especially with surgical robots, as well as longer average operative times for MIS UNC procedures may also be reflected in this finding [17,21,24,2931].

In spite of its rich history and high efficacy, open UNC is inherently more invasive, requiring larger incisions and dissection compared with MIS-UNC. These attributes often necessitate lengthier postoperative hospitalization and recovery times, likely contributing to the greater average LOS for open UNC patients observed in our own analysis and by others [24]. The larger incision is also associated with poorer cosmesis, which is a non-trivial consideration in children given the length of time they will bear visible post-surgical scars; evidence suggests larger surgical scars are associated with decreased parent and patient satisfaction [23]. However, it is worth noting that a standard Pfannenstiel incision is rarely seen given its low-lying location, whereas port site incisions may be more visible if they are placed above the belt line.

The findings of our study must be interpreted in the context of study limitations. NIS represents a 20% stratified sample of US hospital admissions. As such, our reported results may not be generalizable to encounters not in the sample pool. However, NIS does provide meticulous tracking of discharge and hospital weights to minimize the risk of sampling bias [32]. Additionally, NIS is a large retrospective administrative database that might be affected by miscoding bias. Our analysis relies on the accuracy of the diagnostic and procedure codes included in NIS; although the accuracy level of NIS is high for an administrative database, it is possible at least some portion of our cohort may be incorrectly coded. However, we have no reason to believe that miscoding errors would be preferentially more likely in either procedure cohort; thus we do not think it is likely that this potential error is a source of bias impacting our results. Furthermore, the NSQIP complications that we identified may represent associated comorbidities and not true postoperative complications, as NIS does not provide temporal relationships between different diagnosis codes. This can be further aggravated by the NSQIP complications being ill-defined, such as “postoperative urinary complications.” Whether this represents a truly significant finding such as frank urinary retention or a potentially minimal issue such as post-MIS oliguria cannot, unfortunately, be teased out from this data source. Despite these limitations, as noted above, the NIS database is rigorously monitored and audited for coding accuracy by AHRQ and, we believe, represents a reasonably reliable panorama of the characteristics of an inpatient surgical cohort.

A similar concern is our inability to tease apart pure laparoscopic from robotic-assisted laparoscopic procedures purely based on procedure codes. Many centers (including our own) do not routinely use robotic-specific codes, thus we did not attempt to differentiate MIS procedures, as the risk of misattribution was prohibitively high. Although there may be specific technical differences between laparoscopic and robotic techniques (and potentially differences in complication rates), we suspect that the grand majority of MIS procedures described here are robotic. Thus, unfortunately, we cannot comment on the potential implications of pre-peritoneal versus intraperitoneal approaches, for example.

Additionally, our analysis likely underestimates the true incidence of postoperative events. Because NIS represents admission-based rather than patient-based data, it is impossible to track a given patient across time. We were not able to assess post-hospital outcomes nor whether individual patients were readmitted or underwent repeat procedures. Our picture of postoperative complications is limited by the inpatient-only nature of NIS, precluding analysis of outpatient encounters not captured in the database, such as those from urgent care and primary care centers where patients may reasonably present post-discharge manifesting symptoms of a postoperative complication. Finally, we are unable to determine the success of each individual UNC procedure in correcting VUR.

The retrospective nature of NIS also limits available data and possible analyses. Detailed patient-level clinical factors such as reflux grade, laterality, prior UTI episodes, renal scarring, and bowel-bladder dysfunction, were not available. It is thus entirely possible that the MIS patients were systematically different from open UNC patients, either because of patient selection or to secular trends; it is also possible that pediatric urologists who offer MIS UNC might recommend open UNC to some patients and MIS to others, which might potentially affect our reported complication rate. It is important to bear in mind that modality of choice is likely multifactorial and provider/setting-specific. Either open or MIS UNC may be a more appropriate approach for a particular child based on institutional resources, provider proficiency, and patient/parental preferences. Therefore, we chose to present these data without the suggestion that one modality is “better” than another, but rather as a snapshot reflective of contemporary clinical practice patterns and outcomes, which will hopefully pique interest in future prospective trials investigating this subject and a robust discussion of the merits of each approach as new clinical guidelines are formulated by advisory groups.

Conclusion

Compared with open surgery, MIS UNC was used in far fewer cases for the surgical management of VUR between 1998 and 2012; the use of MIS increased over the study period but remained relatively rare. Pediatric patients undergoing MIS UNC experienced shorter LOS but higher costs than open surgical patients. Postoperative complications were rare in both groups, but higher postoperative urinary complication rates appeared to be more common among MIS patients. Further study is needed to assess the factors influencing treatment choice and outcomes between these two modalities, as well as their economic impact.

Highlight.

Ureteroneocystostomy (UNC) is the gold standard for surgical correction of vesicoureteral reflux (VUR). However data comparing surgical outcomes between open and minimally-invasive UNC is scarce. Compared to open surgery, we found that MIS UNC was associated with shorter LOS, higher costs and potentially higher urinary complication rates.

Acknowledgments

Funding

Dr. Routh is supported in part by grant K08-DK100534 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funding source had no role in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.

Footnotes

Conflict of interest

None.

Ethical Approval: This protocol was reviewed by the Duke Institutional Review Board and deemed exempt from review. Administrative approval was given by HCUP.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Pohl HG, Joyce GF, Wise M, Cilento BG., Jr Vesicoureteral Reflux and Ureteroceles. J Urol. 2007;177:1659–66. doi: 10.1016/j.juro.2007.01.059. [DOI] [PubMed] [Google Scholar]
  • 2.Spencer JD, Schwaderer A, McHugh K, Vanderbrink B, Becknell B, Hains DS. The demographics and costs of inpatient vesicoureteral reflux management in the USA. Pediatr Nephrol. 2011;26:1995–2001. doi: 10.1007/s00467-011-1900-3. [DOI] [PubMed] [Google Scholar]
  • 3.Shah KJ, Robins DG, White RH. Renal scarring and vesicoureteric reflux. Arch Dis Child. 1978;53:210–7. doi: 10.1136/adc.53.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Heidenreich A, Ozgur E, Becker T, Haupt G. Surgical management of vesicoureteral reflux in pediatric patients. World J Urol. 2004;22:96–106. doi: 10.1007/s00345-004-0408-x. [DOI] [PubMed] [Google Scholar]
  • 5.Estrada CR, Jr, Passerotti CC, Graham DA, Peters CA, Bauer SB, Diamond DA, et al. Nomograms for Predicting Annual Resolution Rate of Primary Vesicoureteral Reflux: Results From 2,462 Children. J Urol. 2009;182:1535–41. doi: 10.1016/j.juro.2009.06.053. [DOI] [PubMed] [Google Scholar]
  • 6.Elder JS, Peters CA, Arant BS, Jr, Ewalt DH, Hawtrey CE, Hurwitz RS, et al. Pediatric Vesicoureteral Reflux Guidelines Panel Summary Report on the Management of Primary Vesicoureteral Reflux in Children. J Urol. 1997;157:1846–51. [PubMed] [Google Scholar]
  • 7.Peters CA, Skoog SJ, Arant BS, Jr, Copp HL, Elder JS, Hudson RG, et al. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol. 2010;184:1134–44. doi: 10.1016/j.juro.2010.05.065. [DOI] [PubMed] [Google Scholar]
  • 8.Routh JC, Inman BA, Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics. 2010;125:1010–19. doi: 10.1542/peds.2009-2225. [DOI] [PubMed] [Google Scholar]
  • 9.Grimsby GM, Dwyer ME, Jacobs MA, Ost MC, Schneck FX, Cannon GM, et al. Multi-institutional review of outcomes of robot-assisted laparoscopic extravesical ureteral reimplantation. J Urol. 2015;193:1791–5. doi: 10.1016/j.juro.2014.07.128. [DOI] [PubMed] [Google Scholar]
  • 10.Prosser LA, Lamarand K, Gebremariam A, Wittenberg E. Measuring family HRQoL spillover effects using direct health utility assessment. Med Decis Making. 2015;35:81–93. doi: 10.1177/0272989X14541328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Best WR, Khuri SF, Phelan M, Hur K, Henderson WG, Demakis JG, et al. Identifying patient preoperative risk factors and postoperative adverse events in administrative databases: results from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Am Coll Surg. 2002;194:257–66. doi: 10.1016/s1072-7515(01)01183-8. [DOI] [PubMed] [Google Scholar]
  • 12.Khuri SF, Daley J, Henderson W, Hur K, Demakis J, Aust JB, et al. The Department of Veterans Affairs’ NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg. 1998;228:491–507. doi: 10.1097/00000658-199810000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Glenn JF, Anderson EE. Distal tunnel ureteral reimplantation. J Urol. 1967;97:623–6. doi: 10.1016/S0022-5347(17)63089-1. [DOI] [PubMed] [Google Scholar]
  • 14.Politano VA, Leadbetter WF. An operative technique for the correction of vesicoureteral reflux. J Urol. 1958;79:932–41. doi: 10.1016/S0022-5347(17)66369-9. [DOI] [PubMed] [Google Scholar]
  • 15.Elder JS, Peters CA, Arant BS, Jr, Ewalt DH, Hawtrey CE, Hurwitz RS, et al. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol. 1997;157:1846–51. [PubMed] [Google Scholar]
  • 16.Ehrlich RM, Gershman A, Fuchs G. Laparoscopic vesicoureteroplasty in children: initial case reports. Urology. 1994;43:255–61. doi: 10.1016/0090-4295(94)90058-2. [DOI] [PubMed] [Google Scholar]
  • 17.Schober MS, Jayanthi VR. Vesicoscopic ureteral reimplant: is there a role in the age of robotics? Urologic Clin North Am. 2015;42:53–9. doi: 10.1016/j.ucl.2014.09.005. [DOI] [PubMed] [Google Scholar]
  • 18.Okamura K, Yamada Y, Tsuji Y, Sakakibara T, Kondo A, Ono Y, et al. Endoscopic trigonoplasty in pediatric patients with primary vesicoureteral reflux: preliminary report. J Urol. 1996;156:198–200. [PubMed] [Google Scholar]
  • 19.Lakshmanan Y, Fung LC. Laparoscopic extravesicular ureteral reimplantation for vesicoureteral reflux: recent technical advances. J Endourol. 2000;14:589–93. doi: 10.1089/08927790050152203. discussion 593–4. [DOI] [PubMed] [Google Scholar]
  • 20.Kutikov A, Guzzo TJ, Canter DJ, Casale P. Initial experience with laparoscopic transvesical ureteral reimplantation at the Children’s Hospital of Philadelphia. J Urol. 2006;176:2222–5. doi: 10.1016/j.juro.2006.07.082. discussion 2225–6. [DOI] [PubMed] [Google Scholar]
  • 21.Marchini GS, Hong YK, Minnillo BJ, Diamond DA, Houck CS, Meier PM, et al. Robotic assisted laparoscopic ureteral reimplantation in children: case matched comparative study with open surgical approach. J Urol. 2011;185:1870–5. doi: 10.1016/j.juro.2010.12.069. [DOI] [PubMed] [Google Scholar]
  • 22.Akhavan A, Avery D, Lendvay TS. Robot-assisted extravesical ureteral reimplantation: outcomes and conclusions from 78 ureters. J Pediatr Urol. 2014;10:864–8. doi: 10.1016/j.jpurol.2014.01.028. [DOI] [PubMed] [Google Scholar]
  • 23.Barbosa JA, Barayan G, Gridley CM, Sanchez DC, Passerotti CC, Houck CS, et al. Parent and patient perceptions of robotic vs open urological surgery scars in children. J Urol. 2013;190:244–50. doi: 10.1016/j.juro.2012.12.060. [DOI] [PubMed] [Google Scholar]
  • 24.Smith RP, Oliver JL, Peters CA. Pediatric robotic extravesical ureteral reimplantation: comparison with open surgery. J Urol. 2011;185:1876–81. doi: 10.1016/j.juro.2010.12.072. [DOI] [PubMed] [Google Scholar]
  • 25.Ashley R, Vandersteen D. Mini-ureteroneocystostomy: a safe and effective outpatient treatment for unilateral vesicoureteral reflux. J Urol. 2008;180:1621–4. doi: 10.1016/j.juro.2008.04.081. discussion 1624–5. [DOI] [PubMed] [Google Scholar]
  • 26.Saperston K, Smith J, Putman S, Matern R, Foot L, Wallis C, et al. Endoscopic subureteral injection is not less expensive than outpatient open reimplantation for unilateral vesicoureteral reflux. J Urol. 2008;180:1626–9. doi: 10.1016/j.juro.2008.05.124. discussion 1629–30. [DOI] [PubMed] [Google Scholar]
  • 27.Kasturi S, Sehgal SS, Christman MS, Lambert SM, Casale P. Prospective long-term analysis of nerve-sparing extravesical robotic-assisted laparoscopic ureteral reimplantation. Urology. 2012;79:680–3. doi: 10.1016/j.urology.2011.10.052. [DOI] [PubMed] [Google Scholar]
  • 28.Lendvay T. Adv Urol. 2008. Robotic-assisted laparoscopic management of vesicoureteral reflux; p. 732942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hayashi Y, Mizuno K, Kurokawa S, Nakane A, Kamisawa H, Nishio H, et al. Extravesical robot-assisted laparoscopic ureteral reimplantation for vesicoureteral reflux: initial experience in Japan with the ureteral advancement technique. Int J Urol. 2014;21:1016–21. doi: 10.1111/iju.12483. [DOI] [PubMed] [Google Scholar]
  • 30.Morelli L, Cobuccio L, Lorenzoni V, Guadagni S, Palmeri M, Di Franco G, et al. PCN88 - Five-Years Experience of Robotic Vs Laparoscopic Colorectal Cancer Surgery in a Single Center: Surgical Parameters and Costs. Value Health. 2015;18:A445. [Google Scholar]
  • 31.Mahida JB, Cooper JN, Herz D, Diefenbach KA, Deans KJ, Minneci PC, et al. Utilization and costs associated with robotic surgery in children. J Surg Res. 2015;199:169–76. doi: 10.1016/j.jss.2015.04.087. [DOI] [PubMed] [Google Scholar]
  • 32.Elsamra SE, Theckumparampil N, Garden B, Alom M, Waingankar N, Leavitt DA, et al. Open, Laparoscopic, and Robotic Ureteroneocystotomy for Benign and Malignant Ureteral Lesions: A Comparison of Over 100 Minimally Invasive Cases. J Endourol. 2014;28:1455–9. doi: 10.1089/end.2014.0243. [DOI] [PubMed] [Google Scholar]

RESOURCES